Highly efficient induction and long-term maintenance of multipotent cardiovascular progenitors from human pluripotent stem cells under defined conditions

Cell Research

Volumn 23, Issue 9, 2013, Pages 1119-1132

  Cao, Nan ^a   Liang, He ^a   Huang, Jijun ^a   Wang, Jia ^a   Chen, Yixiong ^a   Chen, Zhongyan ^a   Yang, Huang Tian ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

cardiovascular progenitor cells; chemically defined medium; directed differentiation; human pluripotent stem cells; progenitor maintenance

Indexed keywords

ASCORBIC ACID; BMP4 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN 4; CHIR 99021; GLYCOGEN SYNTHASE KINASE 3; PYRIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ARTICLE; BIOLOGICAL THERAPY; CELL CULTURE; CELL DIFFERENTIATION; CULTURE TECHNIQUE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; EMBRYONIC STEM CELL; HEART; HEART DISEASE; HEART MUSCLE; HUMAN; METABOLISM; PLURIPOTENT STEM CELL; PRENATAL DEVELOPMENT;

ASCORBIC ACID; BONE MORPHOGENETIC PROTEIN 4; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL- AND TISSUE-BASED THERAPY; CELLS, CULTURED; EMBRYONIC STEM CELLS; GLYCOGEN SYNTHASE KINASE 3; HEART; HEART DISEASES; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MYOCARDIUM; PYRIDINES; PYRIMIDINES;

EID: 84883465408     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2013.102     Document Type: Article

References (41)

1. Burridge PW, Keller G, Gold JD, Wu JC. Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell 2012; 10:16-28.
2. Mummery CL, Zhang J, Ng ES, et al. Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ Res 2012; 111:344-358.
3. Blin G, Neri T, Stefanovic S, Puceat M. Human embryonic and induced pluripotent stem cells in basic and clinical research in cardiology. Curr Stem Cell Res Ther 2010; 5:215-226.
4. Murry CE, Keller G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 2008; 132:661-680.
5. Kattman SJ, Witty AD, Gagliardi M, et al. Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 2011; 8:228-240.
6. Sone M, Itoh H, Yamahara K, et al. Pathway for differentiation of human embryonic stem cells to vascular cell components and their potential for vascular regeneration. Arterio-scler Thromb Vasc Biol 2007; 27:2127-2134.
7. Cheung C, Bernardo AS, Trotter MW, Pedersen RA, Sinha S. Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility. Nat Biotechnol 2012; 30:165-173.
8. Lian X, Hsiao C, Wilson G, et al. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci USA 2012; 109:E1848-E1857.
9. Zhang J, Klos M, Wilson GF, et al. Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method. Circ Res 2012; 111:1125-1136.
10. Minami I, Yamada K, Otsuji TG, et al. A small molecule that promotes cardiac differentiation of human pluripotent stem cells under defned, cytokine-and xeno-free conditions. Cell Rep 2012; 2:1448-1460.
11. Hentze H, Soong PL, Wang ST, et al. Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies. Stem Cell Res 2009; 2:198-210.
12. Laflamme MA, Chen KY, Naumova AV, et al. Cardiomyo-cytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007; 25:1015-1024.
13. van Laake LW, Passier R, Monshouwer-Kloots J, et al. Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res 2007; 1:9-24.
14. Cao F, Wagner RA, Wilson KD, et al. Transcriptional and functional profiling of human embryonic stem cell-derived cardiomyocytes. PLoS One 2008; 3:e3474.
15. Lam JT, Moretti A, Laugwitz KL. Multipotent progenitor cells in regenerative cardiovascular medicine. Pediatr Cardiol 2009; 30:690-698.
16. Noseda M, Peterkin T, Simoes FC, Patient R, Schneider MD. Cardiopoietic factors: extracellular signals for cardiac lineage commitment. Circ Res 2011; 108:129-152.
17. Yang L, Soonpaa MH, Adler ED, et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 2008; 453:524-528.
18. Mauritz C, Martens A, Rojas SV, et al. Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction. Eur Heart J 2011; 32:2634-2641.
19. Bu L, Jiang X, Martin-Puig S, et al. Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature 2009; 460:113-117.
20. Blin G, Nury D, Stefanovic S, et al. A purifed population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. J Clin Invest 2010; 120:1125-1139.
21. Elliott DA, Braam SR, Koutsis K, et al. NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardio-myocytes. Nat Methods 2011; 8:1037-1040.
22. Cao N, Liu Z, Chen Z, et al. Ascorbic acid enhances the cardiac differentiation of induced pluripotent stem cells through promoting the proliferation of cardiac progenitor cells. Cell Res 2012; 22:219-236.
23. Watanabe K, Ueno M, Kamiya D, et al. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol 2007; 25:681-686.
24. Leschik J, Stefanovic S, Brinon B, Puceat M. Cardiac commitment of primate embryonic stem cells. Nat Protoc 2008; 3:1381-1387.
25. Bondue A, Blanpain C. Mesp1: a key regulator of cardiovascular lineage commitment. Circ Res 2010; 107:1414-1427.
26. Moretti A, Bellin M, Jung CB, et al. Mouse and human induced pluripotent stem cells as a source for multipotent Isl1+ cardiovascular progenitors. FASEB J 2010; 24:700-711.
27. Nelson TJ, Faustino RS, Chiriac A, et al. CXCR4+/FLK-1+ biomarkers select a cardiopoietic lineage from embryonic stem cells. Stem Cells 2008; 26:1464-1473.
28. Bondue A, Tannler S, Chiapparo G, et al. Defning the earliest step of cardiovascular progenitor specifcation during embryonic stem cell differentiation. J Cell Biol 2011; 192:751-765.
29. Burridge PW, Thompson S, Millrod MA, et al. A universal system for highly effcient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PLoS One 2011; 6:e18293.
30. Bondue A, Lapouge G, Paulissen C, et al. Mesp1 acts as a master regulator of multipotent cardiovascular progenitor specifcation. Cell Stem Cell 2008; 3:69-84.
31. Uosaki H, Fukushima H, Takeuchi A, et al. Effcient and scalable purifcation of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression. PLoS One 2011; 6:e23657.
32. Chan SS, Shi X, Toyama A, et al. Mesp1 patterns mesoderm into cardiac, hematopoietic, or skeletal myogenic progenitors in a context-dependent manner. Cell Stem Cell 2013; 12:587-601.
33. Laugwitz KL, Moretti A, Caron L, Nakano A, Chien KR. Islet1 cardiovascular progenitors: a single source for heart lineages? Development 2008; 135:193-205.
34. Moretti A, Caron L, Nakano A, et al. Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and en-dothelial cell diversifcation. Cell 2006; 127:1151-1165.
35. Qyang Y, Martin-Puig S, Chiravuri M, et al. The renewal and differentiation of Isl1+ cardiovascular progenitors are controlled by a Wnt/beta-catenin pathway. Cell Stem Cell 2007; 1:165-179.
36. Cohen ED, Wang Z, Lepore JJ, et al. Wnt/beta-catenin signaling promotes expansion of Isl-1-positive cardiac progenitor cells through regulation of FGF signaling. J Clin Invest 2007; 117:1794-1804.
37. Christoforou N, Miller RA, Hill CM, et al. Mouse ES cell-derived cardiac precursor cells are multipotent and facilitate identification of novel cardiac genes. J Clin Invest 2008; 118:894-903.
38. Cai CL, Liang X, Shi Y, et al. Isl1 identifes a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell 2003; 5:877-889.
39. Ying QL, Wray J, Nichols J, et al. The ground state of embryonic stem cell self-renewal. Nature 2008; 453:519-523.
40. Li C, Zhou J, Shi G, et al. Pluripotency can be rapidly and ef-fciently induced in human amniotic fuid-derived cells. Hum Mol Genet 2009; 18:4340-4349.
41. Cao N, Liao J, Liu Z, et al. In vitro differentiation of rat embryonic stem cells into functional cardiomyocytes. Cell Res2011; 21:1316-1331.